Genius Group Limited rose 1.38% in after-hours trading. The company's subsidiary, Armorgenix, appointed Eric Sauer as its new Chief Operating Officer. This strategic hire follows Buscar's acquisition of a 70% stake in Armorgenix, strengthening the company's portfolio in natural resources, sustainable technologies, and innovative pharmaceuticals. Sauer's extensive experience in pharmacy, naturopathy, and holistic medicine is expected to advance Armorgenix's enzyme-based therapies and antiviral products.
Comments
No comments yet